Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management

Immune checkpoint inhibitors (ICIs) target programmed cell death (PD) 1 receptor and its ligand PD-L1, and have become an integral part of treatment regimens in many cancers including lung cancer, renal cell carcinoma, melanoma, and more. Cancer is associated with a significantly increased risk of v...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tzu-Fei, Carrier, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047296/
https://www.ncbi.nlm.nih.gov/pubmed/36975443
http://dx.doi.org/10.3390/curroncol30030230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047296/
https://www.ncbi.nlm.nih.gov/pubmed/36975443
http://dx.doi.org/10.3390/curroncol30030230

Ejemplares similares